Dr. Michael A. Morris, M.D.
Radiology (Diagnostic Radiology Physician)
- Medicare participating
At a glance
- Medical school
- University of Maryland School of Medicine (2013)
- Years since graduation
- 13
- In the NPI registry since
- 2013
- Medicare patients seen, 2024
- 115
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2013Medical school: University of Maryland School of Medicine
- 2013Registered with an NPI (national billing number; not a license date)
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Diagnostic Radiology Physician primary
MD license D0082170 -
Clinical Informatics Physician
FL license ME147821 · MD license D0082170 -
Nuclear Medicine Physician
FL license ME147821 · MD license D0082170
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Tidalhealth Peninsula Regional, Inc Salisbury, MD
- University of MD Baltimore Washington Medical Center Glen Burnie, MD
Medical groups
- Advanced Molecular Imaging and Therapy (5 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 115
- Services billed
- 65,933
- Patients’ average age
- 75
| Service | Times | Patients |
|---|---|---|
| Lutetium lu 177 vipivotide tetraxetan, therapeutic, 1 millicurie | 46,626 | 51 |
| Lutetium lu 177, dotatate, therapeutic, 1 millicurie | 5,600 | 11 |
| Injection, lanreotide, 1 mg | 4,560 | 13 |
| Injection, gadoterate meglumine, 0.1 ml | 3,430 | 18 |
| Injection, dexamethasone sodium phosphate, 1 mg | 2,042 | 61 |
| Calculation of radiation therapy dose | 1,837 | 64 |
| Injection, ondansetron hydrochloride, per 1 mg | 1,634 | 61 |
| Piflufolastat f-18, diagnostic, 1 millicurie | 727 | 83 |
| Nuclear medicine study, whole body | 535 | 60 |
| Nuclear medicine study, spect imaging with concurrent ct scan, at least 2 areas or separate acquisitions, single day imaging, or single area or acquisition over multiple days | 534 | 61 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Ondansetron Odt (ondansetron) Other prescribers in Glen Burnie, MD | 16 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 5 companies reported 20 payments worth $2,784 in total to this clinician.
| Novartis Pharmaceuticals Corporation | $1,431 |
|---|---|
| Siemens Medical Solutions USA, Inc. | $827 |
| Telix Pharmaceuticals | $381 |
| Voximetry, Inc. | $95.75 |
| Bayer HealthCare Pharmaceuticals Inc. | $49.81 |
| Consulting Fee | $1,375 |
|---|---|
| Food and Beverage | $1,099 |
| Travel and Lodging | $310 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation Aug 27, 2025 | Consulting Fee | $1,375 |
| Siemens Medical Solutions USA, Inc. Aug 6, 2025 | Travel and Lodging Biograph Trinion EP CT64 · MI - Nuclear Medicine (incl. PETNET & MIBR) · travel to Knoxville, TN · in-kind | $155 |
| Siemens Medical Solutions USA, Inc. Aug 7, 2025 | Travel and Lodging Biograph Trinion EP CT64 · MI - Nuclear Medicine (incl. PETNET & MIBR) · travel to Knoxville, TN · in-kind | $155 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $245,486 in research payments for these studies, mostly to the institutions running them.
- Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy
E.r. Squibb & Sons, L.l.c. · Active, not recruiting · NCT05477576
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.